Showing results (71-80 of 363) with videos related to
Sort By:
Pageof 37
Revista Medica De Chile|August 27, 2002
Alcohol-induced liver disease: from molecular damage to treatmentJosé C Fernández Checa, Stefano Bellentani, Claudio TiribelliBMC Gastroenterology|March 3, 2012
Effect of intracellular lipid accumulation in a new model of non-alcoholic fatty liver diseaseNorberto C Chavez-Tapia, Natalia Rosso, Claudio TiribelliInternational Journal of Molecular Sciences|July 2, 2021
Bilirubin: A Promising Therapy for Parkinson's DiseaseSri Jayanti, Rita Moretti, Claudio Tiribelli, et al.Annals of Hepatology|July 9, 2022
Immune checkpoint and angiogenic inhibitors for the treatment of hepatocellular carcinoma: It takes two to tangleCaecilia Sukowati, Loraine Kay D Cabral, Claudio TiribelliFrontiers in Pharmacology|March 29, 2021
Life-Long Hyperbilirubinemia Exposure and Bilirubin Priming Prevent In Vitro Metabolic DamageAnnalisa Bianco, Serena Pinci, Claudio Tiribelli, et al.Scientific Reports|February 5, 2020
Obeticholic acid and INT-767 modulate collagen deposition in a NASH in vitro modelBeatrice Anfuso, Claudio Tiribelli, Luciano Adorini, et al.Healthcare (Basel, Switzerland)|August 6, 2021
COVID-19 Lockdown Effect on Not Institutionalized Patients with Dementia and CaregiversRita Moretti, Paola Caruso, Mauro Giuffré, et al.Liver International : Official Journal of the International Association for the Study of the Liver|December 23, 2016
The molecular basis of jaundice: An old symptom revisitedSilvia Gazzin, Flora Masutti, Libor Vitek, et al.European Journal of Gastroenterology & Hepatology|October 19, 2004
The epidemiology of fatty liverStefano Bellentani, Giorgio Bedogni, Lucia Miglioli, et al.International Journal of Molecular Sciences|February 15, 2022
Antiproliferative and Cytotoxic Activities of Fluorescein-A Diagnostic Angiography DyeMária Šranková, Aleš Dvořák, Marek Martínek, et al.Pageof 37